DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Restasis (Cyclosporine Ophthalmic) - Indications and Dosage

 
 



INDICATIONS AND USAGE

RESTASIS ® ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.

DOSAGE AND ADMINISTRATION

Invert the unit dose vial a few times to obtain a uniform, white, opaque emulsion before using. Instill one drop of RESTASIS ® ophthalmic emulsion twice a day in each eye approximately 12 hours apart. RESTASIS ® can be used concomitantly with artificial tears, allowing a 15 minute interval between products. Discard vial immediately after use.

HOW SUPPLIED

RESTASIS ® ophthalmic emulsion is packaged in single use vials. Each vial contains 0.4 mL fill in a 0.9 mL LDPE vial; 30 vials are packaged in a polypropylene tray with an aluminum peelable lid. The entire contents of each tray (30 vials) must be dispensed intact. RESTASIS ® is also provided in a 60 count (2 x 30) package (one month supply) that must be dispensed intact.

30 Vials 0.4 mL each - NDC 54868-4793-1

Storage: Store RESTASIS ® ophthalmic emulsion at 15 - 25° C (59 - 77° F).

KEEP OUT OF THE REACH OF CHILDREN.

Rx Only

Revised: 02/2010

© 2010 Allergan, Inc.
Irvine, CA 92612, U.S.A.
® marks owned by Allergan, Inc.
U.S. Patent 5,474,979
Made in the U.S.A.

71876US14B



Relabeling of "Additional" bar code label by:
Physicians Total Care, Inc.
Tulsa, OK      74146

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017